Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYP3A5 polymorphism and tacrolimus trough concentration after kidney transplantation
ChiCTR2000029257Phase 4Recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Jan 2020
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus in Kidney allograft status (RTx), sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoints: genotype and body weight. Started Jan 2020; status: recruiting.
02
Drugs
tacrolimus
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on ChiCTR2000029257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029257.